Skip to content
PeptideFactSheets

Research, translated

Clinical trials without the alphabet soup.

A phase number tells you what researchers are trying to learn—not that a medicine works or will be approved.

By the PeptideFactSheets Editorial Team. Claims are source-checked under our editorial policy; clinician review is identified only when a named reviewer is shown.

Preclinical research

Before broad human testing, researchers may study a compound in cells, tissues, or animals. This can reveal mechanisms and obvious hazards, but it cannot prove a treatment works safely in people.

Phase 1: first questions in people

Phase 1 generally focuses on safety, tolerability, and what the body does with a drug. These studies are often small. They may include healthy volunteers or people with a condition, depending on the research.

Phase 2: does the signal hold up?

Phase 2 studies explore effectiveness, dose selection, and continued safety in people with the target condition. Encouraging Phase 2 results still need confirmation.

Phase 3: larger confirmation

Phase 3 trials are usually larger and designed to confirm benefits and characterize harms in the population intended for a potential label. A Phase 3 trial can fail, be delayed, or answer only a narrow question.

FDA review

A sponsor submits a formal application with clinical, manufacturing, and labeling information. FDA review is separate from trial registration and from a company announcing topline results.

Approval versus off-label use

Approval covers the product and uses described in its label. Licensed clinicians may sometimes prescribe an approved medicine off-label, but that does not make the off-label use FDA approved. This site does not recommend treatment choices.

Why early results can be misleading

  • Small studies can exaggerate effects by chance.
  • A press release may arrive before peer review or complete data.
  • Dropouts and missing data can change the story.
  • A surrogate endpoint may not predict how people feel or function.
  • Rare harms often require larger or longer studies to detect.

How to read a trial update

  • Check whether the result is registered, complete, and peer reviewed.
  • Look for the primary endpoint—not only favorable secondary findings.
  • Compare absolute results, adverse events, and discontinuations.
  • Ask whether the comparison group and population fit the claim.
  • Treat estimated completion dates as estimates, not promises.
Peptide research updatesSee how we separate milestones from results.What FDA approval meansLearn why approval is product- and use-specific.Peptide comparisonsCompare status and evidence side by side.